HUP0104928A2 - Mikronizált nátrium-kolisztin-metánszulfonátot tartalmazó gyógyszerkészítmény, eljárás előállítására és alkalmazása - Google Patents
Mikronizált nátrium-kolisztin-metánszulfonátot tartalmazó gyógyszerkészítmény, eljárás előállítására és alkalmazásaInfo
- Publication number
- HUP0104928A2 HUP0104928A2 HU0104928A HUP0104928A HUP0104928A2 HU P0104928 A2 HUP0104928 A2 HU P0104928A2 HU 0104928 A HU0104928 A HU 0104928A HU P0104928 A HUP0104928 A HU P0104928A HU P0104928 A2 HUP0104928 A2 HU P0104928A2
- Authority
- HU
- Hungary
- Prior art keywords
- natrium
- preparation
- pharmaceutical compositions
- colistin sulphomethate
- micronised colistin
- Prior art date
Links
- 108010078777 Colistin Proteins 0.000 title 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 title 1
- 229960003346 colistin Drugs 0.000 title 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 title 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 208000032376 Lung infection Diseases 0.000 abstract 1
- 239000012876 carrier material Substances 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- IQWHCHZFYPIVRV-UHFFFAOYSA-I pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatome Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].CCC(C)CCCCC(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC(C(C)O)C(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCNCS([O-])(=O)=O)NC1=O IQWHCHZFYPIVRV-UHFFFAOYSA-I 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A tal lm ny mikroniz lt n trium-kolisztin-met nszulfon tot tartalmazógyógyszerkészítményekre vonatkozik. A tal lm ny szerinti mikroniz ltgyógyszerkészítmény valamilyen hordozóanyaggal, így laktózzal együttalkalmazható. A tal lm ny szerinti gyógyszerkészítmények kül"nb"zőtart lyokba, így zselatin kapszul kba csomagolhatók és porinhal l sútj n tüdőfertőzés kezelésére alkalmazhatók. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9820746.7A GB9820746D0 (en) | 1998-09-23 | 1998-09-23 | Micronised pharmaceutical compositions |
| PCT/GB1999/003172 WO2000016745A2 (en) | 1998-09-23 | 1999-09-22 | Micronised pharmaceutical compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0104928A2 true HUP0104928A2 (hu) | 2002-04-29 |
| HUP0104928A3 HUP0104928A3 (en) | 2002-08-28 |
| HU228888B1 HU228888B1 (en) | 2013-06-28 |
Family
ID=10839350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104928A HU228888B1 (en) | 1998-09-23 | 1999-09-22 | Pharmaceutical compositions comprising micronised colistin sulphomethate natrium, process for their preparation and their use |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1115380B2 (hu) |
| JP (1) | JP5165168B2 (hu) |
| CN (1) | CN1148168C (hu) |
| AT (1) | ATE267585T1 (hu) |
| AU (1) | AU752266B2 (hu) |
| BR (2) | BRPI9914031B8 (hu) |
| CA (1) | CA2341366C (hu) |
| CZ (1) | CZ298603B6 (hu) |
| DE (1) | DE69917658T3 (hu) |
| DK (1) | DK1115380T4 (hu) |
| EA (1) | EA003193B1 (hu) |
| ES (1) | ES2222733T5 (hu) |
| GB (1) | GB9820746D0 (hu) |
| HU (1) | HU228888B1 (hu) |
| IL (1) | IL141913A0 (hu) |
| MX (1) | MXPA01003103A (hu) |
| NZ (1) | NZ509881A (hu) |
| PL (1) | PL197871B1 (hu) |
| PT (1) | PT1115380E (hu) |
| WO (1) | WO2000016745A2 (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1129705A1 (en) * | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Powder formulation for inhalation |
| SE0303570L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
| WO2005053647A1 (en) * | 2003-12-03 | 2005-06-16 | Microdrug Ag | Medical product containing tiotropium |
| WO2012061902A1 (en) * | 2010-11-12 | 2012-05-18 | Monash University | Micronised spray-dried particles comprising polymyxin |
| SG11201507466XA (en) * | 2013-03-13 | 2015-10-29 | Forest Lab Holdings Ltd | Micronized pharmaceutical compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579846A (en) * | 1984-10-11 | 1986-04-01 | Pfizer Inc. | Antiinflammatory compositions and methods |
| IT1228459B (it) † | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| GB8911259D0 (en) † | 1989-05-17 | 1989-07-05 | Fisons Plc | Inhalation medicament |
| US5916596A (en) † | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| IS1796B (is) * | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
| US5875776A (en) † | 1996-04-09 | 1999-03-02 | Vivorx Pharmaceuticals, Inc. | Dry powder inhaler |
| DE69705414T2 (de) * | 1996-11-15 | 2002-05-02 | Pathogenesis Corp., Seattle | Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege |
-
1998
- 1998-09-23 GB GBGB9820746.7A patent/GB9820746D0/en not_active Ceased
-
1999
- 1999-09-22 WO PCT/GB1999/003172 patent/WO2000016745A2/en active IP Right Grant
- 1999-09-22 CN CNB998113360A patent/CN1148168C/zh not_active Expired - Lifetime
- 1999-09-22 EA EA200100253A patent/EA003193B1/ru not_active IP Right Cessation
- 1999-09-22 CA CA002341366A patent/CA2341366C/en not_active Expired - Lifetime
- 1999-09-22 PL PL346774A patent/PL197871B1/pl unknown
- 1999-09-22 ES ES99949133T patent/ES2222733T5/es not_active Expired - Lifetime
- 1999-09-22 BR BRPI9914031A patent/BRPI9914031B8/pt unknown
- 1999-09-22 NZ NZ509881A patent/NZ509881A/xx not_active IP Right Cessation
- 1999-09-22 HU HU0104928A patent/HU228888B1/hu active Protection Beyond IP Right Term
- 1999-09-22 PT PT99949133T patent/PT1115380E/pt unknown
- 1999-09-22 MX MXPA01003103A patent/MXPA01003103A/es active IP Right Grant
- 1999-09-22 JP JP2000573706A patent/JP5165168B2/ja not_active Expired - Lifetime
- 1999-09-22 DE DE69917658T patent/DE69917658T3/de not_active Expired - Lifetime
- 1999-09-22 AT AT99949133T patent/ATE267585T1/de not_active IP Right Cessation
- 1999-09-22 CZ CZ20011050A patent/CZ298603B6/cs not_active IP Right Cessation
- 1999-09-22 AU AU62122/99A patent/AU752266B2/en not_active Expired
- 1999-09-22 IL IL14191399A patent/IL141913A0/xx not_active IP Right Cessation
- 1999-09-22 BR BRPI9914031-4A patent/BR9914031B1/pt not_active IP Right Cessation
- 1999-09-22 EP EP99949133A patent/EP1115380B2/en not_active Expired - Lifetime
- 1999-09-22 DK DK99949133T patent/DK1115380T4/da active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971889D0 (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| BR0214469A (pt) | 17alfa-alquil-17beta-óxi-estratrienos e produtos intermediários para sua preparação, aplicação dos 17alfa-alquil-17beta-óxi-estratrienos para a preparação de medicamentos bem como preparações farmacêuticas | |
| HUP0301349A2 (hu) | IL-11-tartalmú készítmények | |
| SE8700499L (sv) | Nya farmakologiskt aktiva foreningar | |
| IL108382A0 (en) | Amino acid derivatives, their preparation and pharmaceutical compositions containing them | |
| EP0275005A3 (en) | Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them | |
| NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
| BR0015605A (pt) | Composição e uso | |
| LU90366I2 (fr) | Nasonex | |
| DK0733046T3 (da) | Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter | |
| ATE224717T1 (de) | Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin | |
| IL111674A0 (en) | 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them | |
| ATE202931T1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
| HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
| IL111673A0 (en) | 5,6-Dihydropyrone derivatives and pharmaceutical compositions containing them | |
| HUP0104928A2 (hu) | Mikronizált nátrium-kolisztin-metánszulfonátot tartalmazó gyógyszerkészítmény, eljárás előállítására és alkalmazása | |
| DE69102704D1 (de) | Orales, melatonin enthaltendes arzneimittel. | |
| PL1664123T5 (pl) | Wytwarzanie w dużej skali inhibitora proteinazy alfa-1 i jego zastosowanie | |
| HUP0104206A2 (hu) | (7alfa,17alfa)-17-Hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ont tartalmazó nagy tisztaságú készítmény és eljárás előállítására | |
| HUP0300557A2 (hu) | N-dezacetiltiokolkicin-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
| HUP9902559A2 (hu) | Paracetamolt és drotavenint tartalmazó gyógyszerkészítmény és eljárás előállítására | |
| TR200003451T2 (tr) | Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları | |
| SE9800905D0 (sv) | New therapy in glomerulonephritis | |
| GB1353834A (en) | Benzenesulphonamides | |
| GB1420976A (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC9A | Change of name, address |
Owner name: FOREST LABORATORIES UK LIMITED, GB Free format text: FORMER OWNER(S): PHARMAX LIMITED, GB |
|
| HC9A | Change of name, address |
Owner name: FOREST LABORATORIES UK LIMITED, GB Free format text: FORMER OWNER(S): PHARMAX LIMITED, GB; FOREST LABORATORIES UK LIMITED, GB |
|
| AA1S | Information on application for a supplementary protection certificate |
Free format text: PRODUCT NAME: COLISTIMETHATE SODIUM (COLOBREATHE); REG. NO/DATE: EU/1/11/747/001 20120213 Spc suppl protection certif: S1300067 Filing date: 20131113 Expiry date: 20190922 |